July 23, 2024 — D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, continues to make strides in the development and deployment of quantum computing technology. The company recently announced two major advancements: the introduction of a new hybrid quantum solver and the deployment of a second U.S.-based Advantage quantum computer. D-Wave has revealed plans […]
July 22, 2024 — Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, is inviting investors to a live webinar. Scheduled for July 25, 2024, at 4:15 p.m. ET, this exclusive event will be hosted by RedChip Companies. During the webinar, Nutriband Chairman and President Serguei Melnik and CEO Gareth Sheridan will share insights into […]
July 22, 2024 — SuperCom (NASDAQ: SPCB), a global identity technology provider, reported on July 11 that the company has received new orders from European governments valued at $2.9 million, the third set of orders from European clients in the past 90 days, amounting to a cumulative total of over $11 million in sales during three-month period. “Securing over […]
July 22, 2024 — Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s Disease, has released new data from its Phase III study of buntanetap for early Parkinson’s Disease. The study shows buntanetap is effective in enhancing both motor and cognitive functions, as well as non-motor […]
July 19, 2024 — SuperCom Ltd. (NASDAQ: SPCB), an identification and digital monitoring solutions company, recently secured a new contract for monitoring juveniles transitioning through California’s justice system. “The case management services will be provided for the California client through SuperCom’s fully owned subsidiary, Leaders in Community Alternatives (“LCA”), which provides evidence-based, community-focused services and electronic monitoring programs as […]
July 19, 2024 — Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the receipt of interim results from the first four weeks of dosing in its ongoing diabetes animal study WEIGHT-A24-1. The company noted that the results have already produced several noteworthy findings. According to the announcement, unlimited food and water have been […]
July 19, 2024 — Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to enhancing mitochondrial health and protecting neuronal function to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), have revealed plans to submit a briefing book to the U.S. Food and Drug Administration (“FDA”) by July […]
July 19, 2024 — Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to enhancing mitochondrial health and protecting neuronal function to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), have revealed plans to submit a briefing book to the U.S. Food and Drug Administration (“FDA”) by July […]
July 19, 2024 — D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the findings of a recent study it commissioned with Hyperion Research on enterprise quantum computing adoption plans. Notably, a majority of the surveyed businesses actively engaged in quantum computing anticipate significant […]
July 19, 2024 — D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the findings of a recent study it commissioned with Hyperion Research on enterprise quantum computing adoption plans. Notably, a majority of the surveyed businesses actively engaged in quantum computing anticipate significant […]
July 18, 2024 — SuperCom Ltd. (NASDAQ: SPCB), an identification and digital monitoring solutions company, recently secured a new contract for monitoring juveniles transitioning through California’s justice system. “The case management services will be provided for the California client through SuperCom’s fully owned subsidiary, Leaders in Community Alternatives (“LCA”), which provides evidence-based, community-focused services and electronic monitoring programs as […]
July 18, 2024 — Lexaria’s multi-patented DehydraTECH(TM) “drug delivery platform technology” offers proven increased bioavailability, enhancing the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with speed of onset, and brain absorption of APIs. Strong patents covering this important technology are a critical factor for Lexaria. A robust patent portfolio has always […]
July 18, 2024 — Annovis Bio (NYSE: ANVS), a pioneering biotechnology company, committed to addressing unmet medical needs through innovative research and development efforts, particularly in Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions, is continuing to make significant strides in the field of neurodegenerative diseases with its latest patent filings. The recent announcement is the filing of a […]
July 18, 2024 — Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company is presenting at the 73rd Emerging Growth Conference, scheduled for July […]
July 18, 2024 — Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing that the Massachusetts Executive Office of Energy and Environmental Affairs’ Department of Energy Resources (“DOER”) has approved the company’s 2024 Mullen ONE, an all-electric Class 1 cargo van, for up to $3,500 cash voucher under its MOR-EV program. Managed by DOER and administered […]
July 17, 2024 — Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, and its subsidiary, Bollinger Motors, have announced changes in Bollinger management. According to the announcement, former General Motors (“GM”) executive James Taylor has been appointed CEO, replacing company founder Robert Bollinger; Bollinger, a major shareholder, will remain on the company’s board of directors. Bryan Chambers was […]
July 16, 2024 — Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, and its subsidiary, Bollinger Motors, have contracted to sell 70 all-electric Class 4 Bollinger B4 commercial trucks. The trucks are being purchased by Doering Fleet Management, one of the nation’s premier fleet-management companies, and will be the first class 4, medium duty, all-electric truck offered by […]
July 15, 2024 — Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), will be participating in next week’s Emerging Growth Conference. According to the announcement, members of Clene’s management team will […]
July 12, 2024 — Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is in the process of submitting a briefing book to the U.S. Food and Drug Administration (“FDA”). The company […]
July 12, 2024 — Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing POWER BOOST, a pioneering vehicle battery exchange program for current Class 1 EV cargo van customers. According to the announcement, POWER BOOST allows customers who meet existing vehicle warranty requirements to upgrade their lithium-ion battery packs to solid-state polymer battery packs, increasing vehicle […]
